SinoMab BioScience Limited (stock code: 3681.HK) is a Hong Kong based clinical-phase biopharmaceutical company focus on the development of novel and high-value recombinant therapeutic proteins for treating various life-threatening and debilitating diseases in human.
| Website | http://www.sinomab.com |
| Revenue | $13.9 million |
| Employees | 38 (22 on RocketReach) |
| Founded | 2001 |
| Phone | +1 703-993-8898 |
| Technologies |
JavaScript
,
HTML
,
PHP
+9 more
(view full list)
|
| Industry | Biotechnology, Manufacturing General, Manufacturing |
| Keywords | Bioprocessing, Biopharmaceutical, Novel Therapeutics, Therapeutic Proteins, Recombinant Proteins, Clinical Stage, Drug Development, Biotechnology, Pharmaceutical Research, Immunology, Oncology, Biologics, Monoclonal Antibodies, Protein Engineering, Drug Discovery, Life Sciences, Biosimilars, Clinical Trials, Pharmaceutical Manufacturing, Healthcare |
| Competitors | WuXi AppTec, 百济神州医药信息咨询(上海)有限公司, Zai Lab, Innovent Biologics, I-Mab Biopharma, Sinopharm, CanSino Biologics Inc.康希诺生物, Ascletis Pharma Inc., 微芯生物, Alibaba Health Information Technology +30 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies |
Looking for a particular SinoMab BioScience Ltd. employee's phone or email?
SinoMab BioScience Ltd. Questions
The SinoMab BioScience Ltd. annual revenue was $13.9 million in 2026.
Giselle Lee is the Independent Non-Executive Director of SinoMab BioScience Ltd..
22 people are employed at SinoMab BioScience Ltd..
The NAICS codes for SinoMab BioScience Ltd. are [3254, 325, 32, 32541].
The SIC codes for SinoMab BioScience Ltd. are [28, 283].
Top SinoMab BioScience Ltd. Employees
-
Lucy Lu
人力资源经理 at SinoMab BioScience Ltd.
Suzhou, CN1 -
Chan Sally
Recruiter at SinoMab BioScience Ltd.
New Territories, Hong Kong1 -
婧 杨
PV Head,Associate Director at SinoMab BioScience Ltd.
Beijing, China1
Related Companies
